← FDA Drug Approvals (Drugs@FDA)

ANDA209615

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ACTAVIS LABS FL INC · Approved 2022-05-02

Drug application

FDA Application #

ANDA209615

Application type

Abbreviated New Drug Application (Generic)

Brand name

—

Generic name

—

Active ingredients

—

Dosage form

—

Route

—

Marketing status

—

Sponsor

ACTAVIS LABS FL INC

First approval

2022-05-02

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown